Global Ganja Report

Human Rights Watch (HRW) and several other human rights organizations on April 16 issued a joint statement urging the government of the Republic of Maldives to withdraw plans to end its death penalty moratorium and introduce capital punishment for drug-related crimes.

President Donlad Trump on April 18 signed an executive order calling on the DEA and FDA to open legal pathways for research into the therapeutic benefits of certain Schedule I psychedelic drugs—prominently including ibogaine, with an emphasis on its potential to treat PTSD in military veterans. The order instructs the FDA to collaborate with the Department of Veterans Affairs and the private sector "to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies." 

US air-strikes on so-called "drug boats" have now destroyed 30 vessels and killed more than 100 people in the Caribbean and eastern Pacific. And on Dec. 26, President Donald Trump boasted in a radio interview that the United States had knocked out "a big facility"—implying that it was a drug-trafficking hub on the Venezuelan mainland, although he provided no details and neither the White House, Pentagon nor US intelligence agencies would comment.

Indonesia repatriated two Dutch nationals, one of whom had been on death row, to the Netherlands on Dec. 8, following a bilateral agreement signed between the two countries. Both were convicted of smuggling illegal substances and had been serving lengthy sentences under the Indonesian drug laws before their repatriation.

Amnesty International has urged Singaporean authorities to immediately halt the execution of Pannir Selvam Pranthaman, scheduled for Oct. 8. The Malaysian national has been on death row since 2017 for importing 51.84 grams of diamorphine (heroin) into Singapore. Condemning the practice of mandatory death penalties for drug-related offenses as well as "multiple layers of unfairness" in Pranthaman’s case, Amnesty deemed the case emblematic of the Singaporean justice system's violations of international legal standards.

Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)

Amnesty International on April 24 expressed deep concern over a dramatic increase in executions for drug-related offenses in Saudi Arabia, stressing the fear and uncertainty faced by dozens of men currently on death row. The organization reported that Saudi authorities have executed at least 88 individuals since January, 42 for drug-related crimes, which is almost double the executions for that same period in 2024, none for drug-related crimes. Just this week, in one day on April 22, the Saudi Press Agency announced the execution of three people: two Saudi nationals for “promoting hashish,” and one Pakistani national for “trafficking heroin.” 

Israel is an emerging player in the international cannabis market, and the industry is embraced by pillars of the country’s political establishment. But every aspect of Israeli society as been impacted by the horrific events of last October 7, and the ensuing war. The cannabis sector has been no exception.